New Developments in Breast Cancer Screening and Treatment

被引：4

作者：

Tilstra, Sarah ^{[1
]}

McNeil, Melissa ^{[1
,2
]}

机构：

[1] Univ Pittsburgh, Med Ctr, Div Gen Internal Med, Sect Womens Hlth, Pittsburgh, PA USA

[2] VA Pittsburgh, Dept Vet Affairs, Pittsburgh, PA USA

来源：

JOURNAL OF WOMENS HEALTH | 2017年 / 26卷 / 01期

关键词：

breast cancer; breast cancer treatment; breast cancer screening; breast density; CARCINOMA IN-SITU; BENEFIT; WOMEN;

D O I：

10.1089/jwh.2016.6197

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

The clinical update serves as a brief review of recently published, high-impact, and potentially practice-changing journal articles summarized for our readers. In this clinical update, we selected top recent articles regarding breast health that may change the clinical practice of women's health providers. We identified articles by reviewing high-impact medical and women's health journals as well as national practice guidelines. Three of our articles are dedicated to the rapid changes in breast cancer screening. With regard to breast cancer treatment, we focused on two articles that impact who we treat with traditional aggressive regimens.

引用

页码：5 / 8

页数：4

共 7 条

[1] Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial [J].

Albain, Kathy S. ;

Barlow, William E. ;

Shak, Steven ;

Hortobagyi, Gabriel N. ;

Livingston, Robert B. ;

Yeh, I-Tien ;

Ravdin, Peter ;

Bugarini, Roberto ;

Boehner, Frederick L. ;

Davidson, Nancy E. ;

Sledge, George W. ;

Winer, Eric P. ;

Hudis, Clifford ;

Ingle, James N. ;

Perez, Edith A. ;

Pritchard, Kathleen I. ;

Shepherd, Lois ;

Gralow, Julie R. ;

Yoshizawa, Carl ;

Allred, D. Craig ;

Osborne, C. Kent ;

Hayes, Daniel F. .

LANCET ONCOLOGY, 2010, 11 (01) :55-65

[2]

Carlson Robert W, 2006, J Natl Compr Canc Netw, V4 Suppl 3, pS1

[3]

Ernster VL, 2002, JNCI-J NATL CANCER I, V94, P1546

[4] American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer [J].

Harris, Lyndsay ;

Fritsche, Herbert ;

Mennel, Robert ;

Norton, Larry ;

Ravdin, Peter ;

Taube, Sheila ;

Somerfield, Mark R. ;

Hayes, Daniel F. ;

Bast, Robert C., Jr. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) :5287-5312

[5] Characterizing the impact of 25 years of DCIS treatment [J].

Ozanne, Elissa M. ;

Shieh, Yiwey ;

Barnes, James ;

Bouzan, Colleen ;

Hwang, E. Shelley ;

Esserman, Laura J. .

BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (01) :165-173

[6] Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer [J].

Paik, Soonmyung ;

Tang, Gong ;

Shak, Steven ;

Kim, Chungyeul ;

Baker, Joffre ;

Kim, Wanseop ;

Cronin, Maureen ;

Baehner, Frederick L. ;

Watson, Drew ;

Bryant, John ;

Costantino, Joseph P. ;

Geyer, Charles E., Jr. ;

Wickerham, D. Lawrence ;

Wolmark, Norman .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (23) :3726-3734

[7] Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ A Population-Based Cohort Study [J].

Sagara, Yasuaki ;

Mallory, Melissa Anne ;

Wong, Stephanie ;

Aydogan, Fatih ;

DeSantis, Stephen ;

Barry, William T. ;

Golshan, Mehra .

JAMA SURGERY, 2015, 150 (08) :739-745

← 1 →